Gland Pharma, Neuland Laboratories enter long-term CDMO partnership for sterile APIs
The collaboration brings together Neuland’s API development capabilities and Gland Pharma’s sterile manufacturing expertise to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Gland Pharma
Gland Pharma receives USFDA approval for Angiotensin II Acetate injection
Gland Pharma secures 180-day exclusivity for Angiotensin II Acetate Injection following USFDA approval
Gland Pharma secures US FDA approval for Latanoprost Ophthalmic Solution
Product targets treatment of high intraocular pressure in glaucoma and ocular hypertension patients
Gland Pharma receives tentative USFDA approval for Latanoprostene Bunod Ophthalmic Solution
According to IQVIA, the product had US sales of approximately $ 153 million for the twelve months ended December 2023
Gland Pharma receives USFDA approval for Edaravone Injection
The product is used to treat amyotrophic lateral sclerosis (ALS)
Gland Pharma enters into a Put Option Agreement to acquire 100 per cent of Cenexi Group
The proposed acquisition remains subject to receipt of necessary regulatory approvals and satisfaction of certain conditions
Dr Reddy’s launches Ertapenem for Injection in US
Dr Reddy’s Ertapenem for Injection, 1 g/vial, is available in packs of 10 vials per carton
Gland Pharma gets US FDA nod for generic Foscarnet Sodium Injection, Single-Dose Bag for Infusion
Foscarnet Sodium Injection is indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS
Gland Pharma signs deal with RDIF for 252 million Sputnik V vaccine doses
Gland Pharma said it would explore more deals for the vaccine
Dr Reddy’s launches OTC Olopatadine Hydrochloride Ophthalmic Solution in US
They are indicated for the temporary relief of eye allergies like itchy eyes due to pollen, ragweed, grass, animal hair and dander